Edelman appoints Kajsa Wilhelmsson
April 8, 2010Medical Communications Edelman, appointment, medical communications
Kajsa Wilhelmsson has joined Edelman’s health practice as director of European health public affairs. She will be based in the …
ICON and Tigermed forge China alliance
April 7, 2010Research and Development CRO, China, ICON
Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
UK recoups cost from unused H1N1 vaccine
April 7, 2010Sales and Marketing GSK, NHS, h1n1
The UK government has agreed a deal with GlaxoSmithKine on surplus supplies of its H1N1 vaccine Pandemrix. The Department of …
Solvay reprimanded for cheques to GPs
April 7, 2010Sales and Marketing Code of Practice, PMCPA, Solvay
Three UK pharma companies have been ‘named and shamed’ for serious breaches of the ABPI’s Code of Practice. Solvay, Pfizer …
Sigma-Aldrich opens large-scale high-potency unit
April 7, 2010Manufacturing and Production Sigma-Aldrich
Sigma-Aldrich has increased its high-potency active pharmaceutical ingredient (HPAPI) production capacity with the opening of a newly-expanded facility that is …
GSK and Crucell to develop malaria vaccine
April 7, 2010Sales and Marketing Crucell, GSK, malaria
GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …
Frank Pitzer made chief executive at NimbleGen
April 7, 2010Research and Development NimbleGen, Roche, appointment, research and development
Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
New consultancy Strategic North launched
April 7, 2010Medical Communications, Sales and Marketing Consultancy, coleiro, marketing, marketing ideas, strategy
A new healthcare industry marketing consultancy based in the North West of England has been launched. Strategic North is a …
Publicis acquires In-Sync
April 6, 2010Medical Communications agency, medical communications, publicis
Global communications group Publicis has acquired Toronto-based In-Sync, a company specialising in healthcare market research. In-Sync will become part of …
Manufacturing news in brief
April 6, 2010Manufacturing and Production NIB, Valeant, Warner Chilcott, baxter
This week’s round-up of recent developments in the pharmaceutical manufacturing arena sees a new facility build for Ireland’s HKPB and …
Conservative claims on cancer drugs disputed
April 6, 2010Sales and Marketing NHS, NICE, election
A think tank has disputed Conservative claims that funds can be diverted to pay for greater access to new cancer …
Warner Chilcott gets Actonel lift
April 6, 2010Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis
Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …
Talking Point: Responding to Trial Emergencies
April 6, 2010Research and Development
Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …
Biosimilars: the great balancing act
April 6, 2010Research and Development biogenerics, biosimilars
Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
Obituary: Sir James Black
April 6, 2010Research and Development appointment, research and development
Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …
Catherine Warne made chief executive at Red Door
April 6, 2010Medical Communications Creston, Red Door, appointment, medical communications
Red Door has made Catherine Warne chief executive as part of a reorganisation that also sees promotions for Catherine Oliver, …
Pfizer first to disclose trial payments
April 1, 2010Research and Development, Sales and Marketing Pfizer, industry reputation, payments
Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …
Roche’s Xeloda widens licence
April 1, 2010Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer
Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …
Historic US reforms favour pharma – for now at least
April 1, 2010Sales and Marketing Obama, US healthcare
The industry will be grateful for some certainty on the future market outlook and, overall, there is a strong belief …
New CRO Celerion rises out of MDS divestment
April 1, 2010Research and Development Celerion, mds
Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
